Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia 54Myelodysplastic Syndromes 42Lymphoma, Non-Hodgkin 19Congenital Abnormalities 15Lymphoma 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Leukemia, Lymphocytic, Chronic, B-Cell 13Hodgkin Disease 13Recurrence 11Leukemia, Myelomonocytic, Chronic 11Leukemia, Myelomonocytic, Acute 10Leukemia, Monocytic, Acute 10Leukemia, Megakaryoblastic, Acute 10Leukemia, Erythroblastic, Acute 10Leukemia, Biphenotypic, Acute 9Neoplasms 8Hematologic Neoplasms 8Multiple Myeloma 7Burkitt Lymphoma 7Anemia, Refractory, with Excess of Blasts 7Leukemia, Myelomonocytic, Juvenile 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Promyelocytic, Acute 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Graft vs Host Disease 5Lymphoma, Mantle-Cell 4

Interventions

Metformin 2thymoglobulin 1fludarabine phosphate 1fludarabine 1bicalutamide 1Saline Solution 1Nutrition Assessment 1Heparin 1Exercise 1Clofarabine 1Caloric Restriction 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Metabolic Diseases × Clofarabine × Clear all
NCT01596699 2020-02-26

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

University of California, San Francisco

Phase 2 Terminated
16 enrolled 11 charts

Bone Marrow Failure Disorders, Metabolic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡